Search
OncoCyte Corp
OCXAdd to Watchlist
3.200USD
0.0000.00%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
91.52MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
4
analysts
Buy
Current Rating
7.000
Target Price
+41.70%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
Total
Median
Average
Company name
Ratings
Analysts
No Data
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is OncoCyte Corp's expected revenue for the next quarter?
OncoCyte Corp's expected revenue is 290.00K.
How have OncoCyte CorpOCX's recent earnings per share performed?
The market expectation was USD -0.34, while OncoCyte CorpOCX's earnings per share (EPS) for the previous quarter was USD -0.30. EPS for the next quarter is expected at USD -0.24.
What is the analyst rating for OncoCyte Corp?
Based on the ratings of OncoCyte Corp's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
